Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Rapid detection of Staphylococcus aureus and Streptococcus pneumoniae by real-time analysis of volatile metabolites

ABSTRACT: Early detection of pathogenic bacteria is needed for rapid diagnostics allowing adequate and timely treatment of infections. In this study, we show that Secondary Electro-Spray Ionization-High Resolution Mass Spectrometry (SESI-HRMS) can be used as a diagnostic tool for rapid detection of bacterial infections as a supportive system for current state of the art diagnostics. Volatile Organic Compounds (VOCs) produced by growing S. aureus or S. pneumoniae cultures on blood agar plates were detected within minutes and allowed for the distinction of these two bacteria on a species and even strain level within hours. Furthermore, we obtained a fingerprint of clinical patient samples within minutes of measurement and predominantly observed a separation of samples containing living bacteria compared to samples with no bacterial growth. Further development of this technique may reduce the time required for microbiological diagnosis and should help to improve patient’s tailored treatment.

INSTRUMENT(S): Direct infusion MS - positive, Direct infusion MS - negative

PROVIDER: MTBLS5085 | MetaboLights | 2022-07-06

REPOSITORIES: MetaboLights

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	01_ID02_IBL_MRS_neg.RAW	Raw
	01_ID02_IBL_MRS_pos.RAW	Raw
	01_ID02_LUT_MRS_neg.RAW	Raw
	01_ID02_LUT_MRS_pos.RAW	Raw
	01_ID07_HVA_SAu_neg.RAW	Raw

Items per page:

1 - 5 of 1182

Similar Datasets

Mass Spectrometry Proteotyping-Based Detection and Identification of Staphylococcus aureus, Escherichia coli and Candida albicans in Blood

Project description:Bloodstream infections (BSIs), the presence of microorganisms in blood, are potentially serious conditions that can quickly develop into sepsis and life-threatening situations. When assessing proper treatment, rapid diagnosis is the key; besides clinical judgement performed by attending physicians, supporting microbiological tests typically are performed, often requiring microbial isolation and culturing steps, which increases the time required for confirming positive cases of BSI. The additional waiting time forces physicians to prescribe broad-spectrum antibiotics and empiric treatment, before determining the precise cause of the disease. Thus, alternative and more rapid cultivation-independent methods are needed to improve clinical diagnostics, supporting prompt and accurate treatment and reducing the development of antibiotic resistance. In this study, a culture-independent workflow for pathogen detection and identification in blood samples was developed, using peptide biomarkers and applying bottom-up proteomics analyses, i.e., so-called ”proteotyping”. To demonstrate the feasibility of detection of blood infectious pathogens using proteotyping, Escherichia coli and Staphylococcus aureus were included in the study, as the most prominent bacterial causes of bacteremia and sepsis, as well as Candida albicans, one of the most prominent causes of fungemia. Model systems including spiked negative blood samples, as well as positive blood cultures, without further culturing steps, were investigated. Furthermore, an experiment designed to study the incubation time needed for correct identification of the infectious pathogens in blood cultures was performed. Compared to the MALDI-TOF MS-based approaches, shotgun proteotyping demonstrated higher sensitivity and accuracy, and required shorter incubation time before detection and identification of the correct pathogen could be accomplished.

2021-07-20 | PXD023033 | Pride

mNGS of Pulmonary Fluid in Immunocompromised Children

Project description:<p>Despite improved diagnostics, pulmonary pathogens in immunocompromised children frequently evade detection, leading to significant mortality. In this study, we performed RNA and DNA-based metagenomic next generation sequencing (mNGS) on 41 lower respiratory samples collected from 34 children. We identified a rich cross-domain pulmonary microbiome containing bacteria, fungi, RNA viruses, and DNA viruses in each patient. Potentially pathogenic bacteria were ubiquitous among samples but could be distinguished as possible causes of disease by parsing for outlier organisms. Potential pathogens were detected in half of samples previously negative by clinical diagnostics. Ongoing investigation is needed to determine the pathogenic significance of outlier microbes in the lungs of immunocompromised children with pulmonary disease. Metatranscriptomic (RNA) sequencing libraries are reported in the manuscript and are included for this release.</p>

| phs001684 | dbGaP

Early detection of food safety and spoilage incidents based on live microbiome profiling and qPCR-based monitoring of indicators

Project description:Early detection of spoilage microorganisms and food pathogens is of major importance in preventing food recalls and foodborne outbreaks. Although constant effort is invested in developing sensitive methods for rapid microbial detection, none of the current methods enables the detection of food pathogens within a few hours; therefore, development of innovative early-warning food-testing strategies are needed. Herein, we assessed a novel strategy that harnesses the microbiome signature of a food product to determine deviations in the abundance of particular community members and detect production defects. Employing the production process of barbecued (BarBQ) pastrami as a model, we characterized the microbiome profiles of the product along the production line using next-generation sequencing of the 16S rRNA gene, concentrating on the live microbiota. Following the establishment of a microbiome dataset representing a properly produced product, we were able to identify shifts in the microbiome profile of a defective batch produced under potassium lactate deficiency. With the identification of Vibrio and Lactobacillus as potential indicator bacteria for potassium lactate deficiency, rapid qPCR assays were designed for their quantification. Aligned with the microbiome profiling results, these qPCR assays were effective for rapid identification of a defective production event. This implies the use of rapid quantification targeting microbiome profile-derived indicator bacteria for in-house detection of defective batches and identification of food-safety and quality events with results obtained on the same day. The suggested strategy should pave the way toward safer and more efficient food-production systems.

2024-08-27 | GSE255249 | GEO

Rapid Acceleration of Diagnostics - Radical (RADx-rad): Virus Counter: Rapid and Sensitive Diagnostics Based on Digital Detection of Individual Pathogens

Project description:Rapid Acceleration of Diagnostics - Radical (RADx-rad): Virus Counter: Rapid and Sensitive Diagnostics Based on Digital Detection of Individual Pathogens

| PRJNA761808 | ENA

Rapid Acceleration of Diagnostics - Radical (RADx-rad): Virus Counter: Rapid and Sensitive Diagnostics Based on Digital Detection of Individual Pathogens

Project description:Rapid Acceleration of Diagnostics - Radical (RADx-rad): Virus Counter: Rapid and Sensitive Diagnostics Based on Digital Detection of Individual Pathogens

| PRJNA761812 | ENA

Rapid Acceleration of Diagnostics - Radical (RADx-rad): Nanobody-based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2

Project description:Rapid Acceleration of Diagnostics - Radical (RADx-rad): Nanobody-based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2

| PRJNA781720 | ENA

Rapid Acceleration of Diagnostics - Radical (RADx-rad): Nanobody-based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2

Project description:Rapid Acceleration of Diagnostics - Radical (RADx-rad): Nanobody-based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2

| PRJNA781722 | ENA

A Dataset for Developing Proteomic Tools in Pathogen Detection via Differential Cell Lysis from Whole Blood Samples

Project description:This data descriptor introduces a curated dataset generated through a methodology that merges differential cell lysis, paired with swift extraction/digestion processes and mass spectrometry-based proteomics, aimed at the specific detection and identification of pathogens such as Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans directly from whole-blood samples. Our protocol offers a rapid and direct diagnostic alternative, circumventing the traditional culture processes and thus facilitating the timely management of diseases like sepsis. We demonstrate the utility of this dataset by proposing a biomarker panel, derived from the proteomic profiles of the aforementioned pathogens, and applying our differential cell lysis protocol to blood samples from 8 sepsis patients. We achieved a sensitivity of 87.5% using parallel reaction monitoring (PRM), thereby providing diagnostics within a seven-hour timeframe without the need for microbial enrichment culture. Moreover, this dataset demonstrates high reproducibility and minimal outliers, solidifying its role as a reference for benchmarking and development of bioinformatic tools for peptide panel in identification for microbial detection, antimicrobial resistance, and epidemiological studies.

2024-08-08 | PXD039165 | Pride

Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens

Project description:The rapid, sensitive and specific detection of SARS-CoV-2 is critical in responding to the current COVID-19 outbreak. Here, we explore the potential of targeted mass spectrometry based proteomics for the detection of SARS-CoV-2 proteins in both research and clinical samples. First, we assessed the limit of detection for several SARS-CoV-2 proteins by parallel reaction monitoring (PRM) mass spectrometry. For Nucleocapsid the limit of detection was found to be in the mid-attomole range (0.9 x 10-12 g). Next, this PRM assay is applied to the detection of viral proteins in in vitro mucus substitutes, as well as in various clinical specimens such as nasopharyngeal swabs and sputum. In this proof-of-concept study SARS-CoV-2 proteins could unambiguously be detected in various clinical samples, suggesting that the sensitivity of this technology may be sufficiently high to further explore its potential role in diagnostics.

2021-10-26 | PXD025294 | Pride

Rapid Acceleration of Diagnostics - Radical (RADx-rad): Wastewater Detection of COVID-19

Project description:Rapid Acceleration of Diagnostics - Radical (RADx-rad): Wastewater Detection of COVID-19

| PRJNA775798 | ENA